Biotinylated Cynomolgus/Rhesus macaque LRRC15/LIB Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00169P-100UG

Biotinylated Cynomolgus/Rhesus macaque LRRC15 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Cynomolgus/Rhesus macaque LRRC15/LIB Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00169P-100UG
Collections: High-quality recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Cynomolgus/Rhesus macaque LRRC15/LIB Protein is expressed from HEK293 with His tag and Avi tag at the C-terminus.It contains Tyr22-Gly538. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | A0A2K5UKB6/F7FSB9 |
Target Symbol | LRRC15/LIB |
Species | Cynomolgus/Rhesus macaque |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Tyr22-Gly538 |
Mol. Weight | The protein has a predicted MW of 61.50 kDa. Due to glycosylation, the protein migrates to 70-90 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Anti-LRRC15 Antibody, hFc Tag at 5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Cynomolgus/Rhesus macaque LRRC15, His Tag with the EC50 of 75.9ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation.- LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro. |